Vardenafil, CAS 224785-90-4

Vardenafil, CAS 224785-90-4
Artikelnummer
MEXHY-B0442-100
Verpackungseinheit
100 mg
Hersteller
MedChemExpress

Verfügbarkeit: wird geladen...
Preis wird geladen...
Product Description: Vardenafil is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. Vardenafil shows inhibitory towards PDE1, PDE6 with IC50s of 180 nM, and 11 nM, while IC50s are >1000 nM for PDE3 and PDE4[1]. Vardenafil competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels[2]. Vardenafil can be used for the research of erectile dysfunction, hepatitis, diabetes[1]-[6].

Applications: Metabolism-protein/nucleotide metabolism

Formula: C23H32N6O4S

Citations: Anim Cells Syst (Seoul). 2019 May 16;23(3):155-163./Life Sci. 15 November 2022, 120992.

References: [1]Ashour AE, et al. Vardenafil dihydrochloride. Profiles Drug Subst Excip Relat Methodol. 2014;39:515-544./[2]Saenz de Tejada I, et al. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil. Int J Impot Res. 2001;13(5):282-290./[3]Gresser U, et al. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature. Eur J Med Res. 2002 Oct 29. 7(10):435-46. /[4]Oudot A, et al. Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: a proof of concept study for the treatment of phosphodiesterase type 5 inhibitor failure. Eur Urol. 2011 Nov. 60(5):1020-6. /[5]Ahmed N, et al. Hepatoprotective role of vardenafil against experimentally induced hepatitis in mice. J Biochem Mol Toxicol. 2017 Mar. 31(3). /[6]Bódi B, et al. Long-Term PDE-5A Inhibition Improves Myofilament Function in Left and Right Ventricular Cardiomyocytes through Partially Different Mechanisms in Diabetic Rat Hearts. Antioxidants (Basel). 2021 Nov 6. 10(11):1776.

CAS Number: 224785-90-4

Molecular Weight: 488.60

Compound Purity: 99.73

Research Area: Endocrinology; Metabolic Disease; Inflammation/Immunology; Cancer

Solubility: DMSO : 25 mg/mL (ultrasonic)

Target: Endogenous Metabolite;Phosphodiesterase (PDE)
Mehr Informationen
Artikelnummer MEXHY-B0442-100
Hersteller MedChemExpress
Hersteller Artikelnummer HY-B0442-100
Verpackungseinheit 100 mg
Mengeneinheit STK
Produktinformation (PDF) Download
MSDS (PDF) Download